PPD appoints Jay Dixon as vice president, global quality and compliance
Tuesday, March 26, 2013
Pharmaceutical Product Development (PPD), a global CRO, has appointed Jay Dixon as senior vice president, global quality and compliance. Dixon’s expertise will enhance PPD’s ability to deliver industry-leading drug development services and high-quality data across the full spectrum of the research and development life cycle.
Dixon is a seasoned executive with more than 27 years of research and development experience in the pharmaceutical and biotechnology industries. Most recently, he was chief operating officer at PRACS Institute, with responsibility for providing strategic direction and leadership to the company’s service lines, quality infrastructure, management and business development activities. Previously, he served as senior vice president of regulatory affairs, quality and compliance, as well as chief compliance officer. In addition, Dixon has served in quality and compliance roles with MedImmune, Abbott Laboratories, GlaxoSmithKline and CROs.
Dixon is a member of the Drug Information Association and the Society of Quality Assurance. He formerly was a member of the board of directors of Frederick Memorial Healthcare System.